STOCK MARKET Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more Dec 17, 2025
CORPORATES Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib Dec 16, 2025
Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market Dec 11, 2025
Top Q2 results today, November 14: Tata Motors PV, Oil India, Glenmark Pharma, MRF and more to announce earnings Nov 14, 2025
Top stocks to watch today, September 25: Tata Motors, NTPC, Glenmark Pharma, Newgen Software, Lupin and more Sep 25, 2025
Glenmark Pharma secures $1.1B deal with Hengrui for exclusive global rights to HER2-targeted therapy Trastuzumab Rezetecan Sep 24, 2025
Glenmark Pharma shares jump over 2% after its subsidiary gets $700 million from AbbVie for licensing deal Sep 9, 2025
Glenmark Pharma receives $700 million upfront payment from AbbVie for global licensing deal Sep 9, 2025
Glenmark Pharma initiates multi-country Phase 3 Clinical Trial for Envafolimab in Stage III NSCLC Sep 5, 2025